micro-community-banner
 
  • Saved


Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial - PubMed

Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34708297/

doi: 10.1007/s00432-021-03796-z. Online ahead of print. 1 Klinik für Nuklearmedizin, Universitätsklinikum Essen, Hufelandstraße 55, 45147 Essen, Germany. [email protected]. 2 Zentrallabor, Universitätsklinikum Essen, Essen, Germany. [email protected]. 3 Klinik für Nuklearmedizin, Universitätsklinikum...

  • Saved

Tafasitamab for refractory/relapsed diffuse large B-cell lymphoma - PubMed

Tafasitamab for refractory/relapsed diffuse large B-cell lymphoma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34586105/

Diffuse large B-cell lymphoma (DLBCL) is a common lymphoproliferative and invasive disease. The current first-line regimen for the treatment of DLBCL is R-CHOP, which is the combination of rituximab, cyclophosphamide,...

  • Saved

Cytoplasmic CD79a is a promising biomarker for B lymphoblastic leukemia follow up post CD19 CAR-T therapy - PubMed

Cytoplasmic CD79a is a promising biomarker for B lymphoblastic leukemia follow up post CD19 CAR-T therapy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34672246/

Minimal residual disease (MRD) detection is an important prognostic parameter in patients with refractory or relapsed B-cell acute lymphoblastic leukemia (R/R B-ALL). CD79a has been reported to exhibit a high...

  • Saved

Assessing CAR T-cell therapy response using genome-wide sequencing of cell-free DNA in patients with B-cell lymphomas - PubMed

Assessing CAR T-cell therapy response using genome-wide sequencing of cell-free DNA in patients with B-cell lymphomas - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34655803/

1 Department of Medicine, Division of Blood and Marrow Transplantation, University of California San Diego, La Jolla, California. Electronic address: [email protected]. 2 Laboratory Corporation of America®, San Diego, California. 3...

  • Saved

Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL - PubMed

Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34660330/

doi: 10.3389/fonc.2021.778039. 1 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking...